光面与毛面假体乳房再造后乳腺癌复发:一项配对队列研究
该配对队列研究比较了光面与毛面假体即刻直接乳房再造患者的乳腺癌复发结局。倾向评分1:2匹配后,光面组138例、毛面组276例,中位随访分别为62个月和66个月。两组局部区域复发、远处转移、首次复发率及5年无复发生存率均无显著差异。
要点
- 匹配后光面组与毛面组局部区域复发率分别为10.9%与11.6%,无显著差异。
- 两组远处转移率分别为3.6%与4.0%,首次复发率分别为12.3%与13.4%,均无显著差异。
- 5年局部区域无复发生存率、无病生存率、无远处转移生存率两组均无显著差异。
核心结论
- 在该配对队列分析中,光面与毛面假体组在原发性乳腺癌即刻直接乳房再造患者的复发结局上无显著差异。
- 作者认为需要进一步更大规模的研究来验证其结果的结论。
研究设计与样本
- 回顾性配对队列研究,纳入2010年1月至2016年12月期间因原发性乳腺癌接受即刻直接假体乳房再造的患者。
- 共纳入590例患者,经倾向评分1:2匹配后,光面假体组138例,毛面假体组276例。
- 比较两组局部区域无复发生存率、无病生存率和无远处转移生存率。
主要发现
- 匹配后光面组与毛面组中位随访时间分别为62个月和66个月。
- 局部区域复发率光面组10.9% vs 毛面组11.6%(p = 0.827),无显著差异。
- 远处转移率光面组3.6% vs 毛面组4.0%(p = 0.547),无显著差异。
- 首次复发率光面组12.3% vs 毛面组13.4%(p = 0.757),无显著差异。
- 5年局部区域无复发生存率光面组89.5% vs 毛面组89.4%(p = 0.840)、无病生存率87.7% vs 88.1%(p = 0.794)、无远处转移生存率98.8% vs 96.8%(p = 0.741),均无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需要进一步更大规模的研究来验证其结果的结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An increasing number of reports on breast implant-associated anaplastic large-cell lymphoma have recently raised concerns about the potential influence of breast implants on carcinogenicity, particularly implants with a textured surface. The authors compared the recurrence outcomes between smooth and textured implant reconstructions for breast cancer. METHODS: All patients who underwent immediate direct-to-implant-based breast reconstruction for primary breast cancer between January of 2010 and December of 2016 were reviewed. A total of 590 patients were included. After propensity score 1:2 matching, 138 patients were included in the smooth implant group and 276 patients in the textured implant group. Locoregional recurrence-free survival, disease-free survival, and distant metastasis-free survival rates were compared between the groups. RESULTS: After matching, the median follow-up periods were 62 months and 66 months for the smooth and textured groups, respectively. The authors observed no significant differences between the smooth and textured implant groups in terms of locoregional recurrence (10.9 percent versus 11.6 percent; p = 0.827), distant metastasis (3.6 percent versus 4.0 percent; p = 0.547), or first recurrence (12.3 percent versus 13.4 percent; p = 0.757) rates. No significant differences were observed between the groups in 5-year locoregional recurrence-free survival (89.5 percent versus 89.4 percent; p = 0.840), disease-free survival (87.7 percent versus 88.1 percent; p = 0.794), or distant metastasis-free survival (98.8 percent versus 96.8 percent; p = 0.741) rates. CONCLUSIONS: No significant differences were observed between the smooth and textured implant groups in this matched cohort analysis of recurrence outcomes in patients with primary breast cancer who underwent immediate direct-to-implant reconstruction. Further larger scale investigations are necessary to validate the authors' results. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Wu ZY, Han HH, Han J, et al. Breast Cancer Recurrence after Smooth versus Textured Implant-Based Breast Reconstruction: A Matched Cohort Study. Plast Reconstr Surg. 2022. PMID: 35943962. doi:10.1097/PRS.0000000000009491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。